Sysmex America Exhibits New Products, Automation and Quality Solutions
By LabMedica International staff writers Posted on 06 Aug 2019 |

Image: The PS-10, designed for complex laboratory-developed tests and routine flow cytometry applications (Photo courtesy of Sysmex America).
Sysmex America, Inc. (Lincolnshire, IL, USA), a diagnostic solutions company offering hematology, urinalysis and flow cytometry testing technology, exhibited its expanded line of products and services at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo.
At AACC 2019, Sysmex demonstrated its products, processes, automation, quality, and best practices in clinical laboratory management. Sysmex showcased its highly automated and flexible PS-10, which is designed for complex laboratory-developed tests and routine flow cytometry applications, providing clinical laboratories with a new level of workflow efficiency and confidence in accurate results. The PS-10 automates sample preparation, alleviating primary operational bottlenecks in busy clinical flow laboratories, as well as eliminating variability between operators. The PS-10 also offers standardization for antibody cocktailing and reduces the amount of manual transferring of samples performed by laboratory staff.
The company also demonstrated its complete blood count (CBC) analyzer, the XN-20, a complementary system to the XN-10, but with an additional analysis channel. The White Precursor Cell (WPC) channel, which provides improved differentiation of abnormal WBC populations, adds further efficiency for laboratories. Also on display at the tradeshow was the UN-2000, Sysmex’s first fully automated urine particle counter and digital imaging system that provides laboratories with a highly standardized and efficient process for urine sediment analysis, one with less manual intervention and greater accuracy. Using fluorescence flow cytometry, the UN-2000 reduces time consuming hands-on review, delivering highly accurate particle quantitation and differentiation through walk-away loading, standardized criteria with high reproducibility, quantitative measurement and automated validation helping the review of the technologist.
In software solutions, Sysmex demonstrated its quality management system BeyondCare Quality Monitor for Hematology (BCQMh), which streamlines the end-to-end process of running controls and reviewing results, leading to improved analyzer productivity. The web-based quality control and calibration verification management program uses evidence-based quality control. Sysmex also highlighted it powerful software solution Caresphere Laboratory Management (LM) for monitoring quality, productivity and efficiency data, enabling labs to optimize their performance. Bringing together crucial elements such as turnaround times, rerun ratios, analyzer conditions and performance metrics, Caresphere LM provides at-a-glance metrics and status updates designed to give labs the information they need without having to search through multiple software systems. Whether managing one site or many, accessing statistics and calibration data is made simple with Caresphere LM.
At AACC 2019, Sysmex demonstrated its products, processes, automation, quality, and best practices in clinical laboratory management. Sysmex showcased its highly automated and flexible PS-10, which is designed for complex laboratory-developed tests and routine flow cytometry applications, providing clinical laboratories with a new level of workflow efficiency and confidence in accurate results. The PS-10 automates sample preparation, alleviating primary operational bottlenecks in busy clinical flow laboratories, as well as eliminating variability between operators. The PS-10 also offers standardization for antibody cocktailing and reduces the amount of manual transferring of samples performed by laboratory staff.
The company also demonstrated its complete blood count (CBC) analyzer, the XN-20, a complementary system to the XN-10, but with an additional analysis channel. The White Precursor Cell (WPC) channel, which provides improved differentiation of abnormal WBC populations, adds further efficiency for laboratories. Also on display at the tradeshow was the UN-2000, Sysmex’s first fully automated urine particle counter and digital imaging system that provides laboratories with a highly standardized and efficient process for urine sediment analysis, one with less manual intervention and greater accuracy. Using fluorescence flow cytometry, the UN-2000 reduces time consuming hands-on review, delivering highly accurate particle quantitation and differentiation through walk-away loading, standardized criteria with high reproducibility, quantitative measurement and automated validation helping the review of the technologist.
In software solutions, Sysmex demonstrated its quality management system BeyondCare Quality Monitor for Hematology (BCQMh), which streamlines the end-to-end process of running controls and reviewing results, leading to improved analyzer productivity. The web-based quality control and calibration verification management program uses evidence-based quality control. Sysmex also highlighted it powerful software solution Caresphere Laboratory Management (LM) for monitoring quality, productivity and efficiency data, enabling labs to optimize their performance. Bringing together crucial elements such as turnaround times, rerun ratios, analyzer conditions and performance metrics, Caresphere LM provides at-a-glance metrics and status updates designed to give labs the information they need without having to search through multiple software systems. Whether managing one site or many, accessing statistics and calibration data is made simple with Caresphere LM.
Latest AACC 2019 News
- Instrumentation Laboratory Presents New IVD Testing System
- Quidel Welcomes Newest Member of Triage Family
- ERBA Mannheim Unveils Next-Generation Automation
- Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond
- BioMérieux Spotlights Diagnostic Solutions in Use of Antibiotics
- Thermo Shows New Clinical Innovations
- Randox Launches New Innovations
- Streck Introduces Three New Antibiotic Resistance Detection Kits
- EKF Diagnostics Highlights Assay for Diabetes Patient Monitoring
- BBI Solutions Showcases Mobile Solutions Capabilities at AACC 2019
- MedTest Dx Releases New Product Line for Drugs of Abuse Testing
- Mesa Biotech Launches Molecular Test System at AACC 2019
- Ortho Clinical Diagnostics Highlights Groundbreaking Lab Technology
- Abbott Diagnostics Exhibits POC Diagnostics Solutions at AACC
- Beckman Coulter Demonstrates Latest Innovations in Lab Medicine
- Orion Diagnostica Showcases Range of Products in Anaheim
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
Portable Blood-Based Device Detects Colon Cancer
Colon cancer is the second leading cause of cancer-related deaths in the U.S., yet it is highly treatable when detected at an early stage. Traditional colonoscopy screenings, although effective, are unpleasant,... Read more
New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
Antimicrobial resistance has emerged as a significant global health threat, causing at least one million deaths annually since 1990. The Global Research on Antimicrobial Resistance (GRAM) Project warns... Read more
Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channelCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read morePathology
view channel
New Test Diagnoses High-Risk Childhood Brain Tumors
Medulloblastoma, which originates in the cerebellum, the rear part of the brain, is the most prevalent malignant brain tumor in children and is notoriously difficult to diagnose. Currently, identifying... Read more
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more